Persistence with teriparatide in patients with osteoporosis: the UK experience

Author： Arden N. Earl S. Fisher D. Cooper C. Carruthers S. Goater M.

ISSN： 0937-941X

Source： Osteoporosis International, Vol.17, Iss.11, 2006-11, pp. : 1626-1629

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adherence and persistence in patients with severe osteoporosis treated with teriparatide

By Ziller V. Zimmermann S.P. Kalder M. Ziller M. Seker-Pektas B. Hellmeyer L. Hadji P.

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 675-681

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice

By Ish-Shalom Sophia Dumitrache Constantin El-Husseini Timour Fikry Hussein Azza Barker Clare Pavo Imre

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

By Foster S. Foley K. Meadows E. Johnston J. Wang S. Pohl G. Long S.

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 551-557

Springer Publishing Company

Access to resources Recommend Favorite

Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis

CLINICAL ENDOCRINOLOGY, Vol. 85, Iss. 4, 2016-10 ,pp. : 556-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of teriparatide and PTH(1–84) for the treatment of osteoporosis

By Wagman Rachel Miller Paul

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-290

Humana Press, Inc

Access to resources Recommend Favorite